Long-Term Low-Dose Pyrimethamine Use for the Prevention of Ocular Toxoplasmosis Recurrences: A Cohort Study.
Yuslay Fernández ZamoraPaula M MarinhoJoão Rafael Oliveira DiasThiago CabralJulio CasoyCristina MuccioliHeloísa Moraes Do NascimentoRubens BelfortPublished in: Ocular immunology and inflammation (2024)
Long-term, low-dose pyrimethamine can be considered as a treatment option for the prevention of ocular toxoplasmosis recurrence in selected patients, with only a few, mild and reversible systemic adverse events.